The Indian Pharmacopoeia (IP) has been recognised formally by the National Department of Regulation of Medicines and Health Products of the Ministry of Public Health of Islamic Republic of Mghanistan on December 21, 2019.

It will also be used based on the requirement as reputable pharmacopeia in the laboratory of medicines and health products quality.

With this, a new beginning has been made and Afghanistan has become the first country to recognise IP pursuant to the efforts of Department of Commerce and Ministry of Health and Family Welfare.

About Indian Pharmacopoeia (IP)
• IP is an officially recognised book of standards as per the Drugs and Cosmetics Act, 1940 and Rules 1945 thereunder.
• The IP specifies the standards of drugs manufactured and marketed in India in terms of their identity, purity and strength.
• The quality, efficacy and safety of the medicines are important from the healthcare perspective. In order to ensure the quality of medicinal products, the legal and scientific standards are provided by the Indian Pharmacopoeia Commission (IPC) in the form of Indian Pharmacopoeia (IP).
• The IP Commission’s mission is to promote public and animal health in India by bringing out authoritative and officially accepted standards for quality of drugs including active pharmaceutical ingredients and dosage forms, used by health professionals, patients and consumers.